Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
Objective: Cancer, one of the principal causes of death, is a global social health problem. Autoantibodies developed against the organism's self-antigens are detected in the sera of subjects with cancer. In recent years carbonic anhydrase (CA) I and II autoantibodies have been shown in some au...
Main Authors: | Ahmet Menteşe, Nergiz Erkut, Selim Demir, Serap Özer Yaman, Aysegül Sümer, Seniz Doğramacı, Ahmet Alver, Mehmet Sönmez |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2017-11-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-44442 |
Similar Items
-
Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia
by: Ahmet Mentese, et al.
Published: (2018-10-01) -
Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
by: Ahmet Mentese, et al.
Published: (2017-05-01) -
The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
by: Nergiz Erkut, et al.
Published: (2016-05-01) -
The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients
by: Adem Türk, et al.
Published: (2017-03-01) -
Carbonic Anhydrase Type II Deficiency Syndrome
by: J Gordon Millichap
Published: (2012-01-01)